.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Citi
Medtronic
Baxter
Dow
Federal Trade Commission
UBS
US Department of Justice
Deloitte
Healthtrust

Generated: September 22, 2017

DrugPatentWatch Database Preview

IBU-TAB Drug Profile

« Back to Dashboard

Which patents cover Ibu-tab, and what generic Ibu-tab alternatives are available?

Ibu-tab is a drug marketed by Alra and is included in four NDAs.

The generic ingredient in IBU-TAB is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and fifty-eight suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

Summary for Tradename: IBU-TAB

Patents:0
Applicants:1
NDAs:4
Bulk Api Vendors: see list110
Clinical Trials: see list148
Patent Applications: see list9,681
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:IBU-TAB at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alra
IBU-TAB
ibuprofen
TABLET;ORAL071058-001Aug 11, 1988ABRXNoNo► Subscribe► Subscribe► Subscribe
Alra
IBU-TAB 200
ibuprofen
TABLET;ORAL071057-001Aug 11, 1988OTCNoNo► Subscribe► Subscribe► Subscribe
Alra
IBU-TAB
ibuprofen
TABLET;ORAL071059-001Aug 11, 1988ABRXNoNo► Subscribe► Subscribe► Subscribe
Alra
IBU-TAB
ibuprofen
TABLET;ORAL071965-001Aug 11, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Express Scripts
Accenture
Citi
Moodys
Johnson and Johnson
Cantor Fitzgerald
Merck
Novartis
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot